Sun Pharmaceuticals reported INR72.22B in Gross Profit on Sales for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Aspen Pharmacare APN:SJ 8.6B 583M
Bharat Petroleum BPCL:IN 111.7B 8B
Cipla CIPLA:IN 33.35B 476.2M
Dr.Reddys Laboratories DRRD:IN 35.24B 2.36B
Jiangsu Hengrui Me. 600276:CH CH 5.88B 399.7M
Reliance Infra RELI:IN IR 588580M 46760M
Sh Fosun Pharma 600196:CH CH 4.47B 581.58M
Sun Pharmaceuticals SUNP:IN IR 72224.4M 1183.7M
UPL UPLL:IN 78.67B 17.24B